Oncology – Page 5 – Medical News Asia

Effect of prior therapy on BRAF V600E-mutant metastatic colorectal cancer

11 June 2021/in Gastrointestinal Cancer, Oncology, Targeted Therapies/by Coco Chong

An exploratory post-hoc analysis of the BEACON CRC study investigated the overall survival (OS) of encorafenib + cetuximab (doublet) and FOLFIRI (control) according to prior therapies (bevacizumab, oxaliplatin, FOLFOXIRI and anticancer therapy [ACT]) in BRAF V600E-mutant metastatic colorectal cancer (mCRC).

The emerging role of targeted therapy in advanced urothelial carcinoma

23 April 2021/in Genitourinary Cancer, Oncology, Immunotherapy, Targeted Therapies/by Kirsty LEE

There is no excerpt because this is a protected post.

Emerging options for the treatment of metastatic hormone-sensitive prostate cancer

23 April 2021/in Genitourinary Cancer, Oncology, Endocrine Therapy/by Kirsty LEE

There is no excerpt because this is a protected post.

Advancing care for advanced renal cell carcinoma: choosing the optimal therapy for you patients

19 April 2021/in Genitourinary Cancer, Oncology, Immunotherapy, Targeted Therapies/by Kirsty LEE

There is no excerpt because this is a protected post.

the-evolving-role-of-nk1-in-cinv-management-chemotherapy-induced-nausea-vomiting-akynzeo-nepa-palonosetron-netupitant-1

The evolving role of NK₁ in CINV management

16 April 2021/in Oncology, Chemotherapy, AE Management/by Stijn van den Borne, MSc

There is no excerpt because this is a protected post.

Lung Cancer Update April 2021

8 April 2021/in Lung Cancer, Oncology, Chemotherapy, Immunotherapy, Radiology, irAE Management, Targeted Therapies/by Kirsty LEE

With the World Conference on Lung Cancer (WCLC) 2020 completed last January, several new and clinical relevant phase 2 and phase 3 studies on Lung Cancer have been published. We summarised some key data for you.

Abemaciclib: A review of the evidence through clinical cases

25 March 2021/in Breast Cancer, Oncology, Chemotherapy, Endocrine Therapy, Radiology, Targeted Therapies/by Kirsty LEE

There is no excerpt because this is a protected post.

The Role of Patient Blood Management for Inflammatory Bowel Disease

27 February 2021/in Therapeutic Areas, Gastroenterology, Haematology/by Kirsty LEE

There is no excerpt because this is a protected post.

Breast cancer update January 2021

1 February 2021/in Breast Cancer, Oncology, Chemotherapy, Endocrine Therapy, Radiology, Targeted Therapies, Translational Research/by Kirsty LEE

With the San Antonio Breast Cancer Conference (SABCS) 2020 by AACR just completed, several new and clinical relevant phase 2 and phase 3 have been published in the Journal of the American Medical Association, Clinical Cancer Research, New England Journal of Medicine, Journal of Clinical Oncology, and Lancet Oncology. [‘mediPr] provides you with an overview.

Osimertinib approved as the first adjuvant treatment for early non-small cell lung cancer

28 January 2021/in Lung Cancer, Oncology, Targeted Therapies/by Kirsty LEE

Lung cancer is a leading cause of cancer-related death. In East Asian non-small cell lung cancer (NSCLC) patients, epidermal growth factor receptor (EGFR) mutations occur in 40-55% of lung adenocarcinomas.